It would be great in Australia if we had some TGA-approved products available to prescribe in the normal way
10.3748/wjg.v22.i41.9127 28 DobricI.DrvisP.PetrovicI.ShejbalD.BrcicL.BlagaicA
This combination helps improve how your body processes carbohydrates, stabilizes blood sugar and ultimately promotes weight loss and reduces inflammation

Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols

B12 injections offer an alternative way to achieve optimal levels
While possession is not illegal (they are not DEA-scheduled substances), the regulatory landscape continues to evolve